Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT00448292

Public ClinicalTrials.gov record NCT00448292. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 3:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of PRX-00023 in Patients With Major Depressive Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this randomized, double-blind, placebo-controlled study is to assess the safety and efficacy of PRX-00023 in patients with major depressive disorder.

Study identification

NCT ID
NCT00448292
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Epix Pharmaceuticals, Inc.
Industry
Enrollment
330 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Not listed
Completion
Nov 2007 (Actual)
Last update posted
Nov 14, 2007

2007

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Vista Medical Research, Inc. Mesa Arizona 85206 —
Pharmacology Research Institute Encino California 91316 —
Pharmacology Research Institute Los Alamitos California 90720 —
Synergy Clinical Research Center National City California 91950 —
Excell Research Oceanside California 92056 —
Pacific Clinical Research Medical Group Riverside California 92506 —
AVI Clinical Research Torrance California 90505 —
Pacific Clinical Research Medical Group Upland California 91786 —
GWU Clinical Psychiatric Research Center Washington D.C. District of Columbia 20037 —
CNS Healthcare of Jacksonville Jacksonville Florida 32216 —
Atlanta Institute of Medicine and Research Atlanta Georgia 30328 —
Chicago Research Center, Inc. Chicago Illinois 60634 —
Vince and Associates Clinical Research Overland Park Kansas 66212 —
Brentwood Research Institute Shreveport Louisiana 71101 —
Piedmont Neuropsychiatry Charlotte North Carolina 28216 —
University of Pennsylvannia Philadelphia Pennsylvania 19140 —
SE Health Consultants, LLC Charleston South Carolina 29407 —
University of Texas - Southwestern Medical Center Dallas Texas 75235 —
R/D Clinical Research, Inc. Lake Jackson Texas 77566 —
Northwest Clinical Research Center Bellevue Washington 98004 —
Summit Research Network Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00448292, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2007 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00448292 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →